Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
AstraZeneca
Pharma
FTC targets Novo's Ozempic among 300-plus 'junk' patents
Similar to its first round of challenge against allegedly improper listings in the FDA's Orange Book, the FTC is again targeting drug-device combos.
Angus Liu
May 1, 2024 7:30am
J&J, BMS set to appeal losses in IRA drug pricing lawsuits
Apr 30, 2024 11:48am
CPI unveils next leg of its digital manufacturing journey
Apr 30, 2024 10:23am
AZ, Daiichi tout Enhertu win in earlier, broader HER2-low cancer
Apr 29, 2024 10:38am
Pharma's reputation falls as pandemic-era halo slips
Apr 29, 2024 2:00am
Novartis, Neurocrine-Takeda, Enhertu—Fierce Pharma Asia
Apr 26, 2024 5:45am